Cosmo
Phase 3Cosmo empowers people to live and work with confidence by innovating at the intersection of science and technology, in the spaces of MedTech AI, dermatology, gastroenterology, and contract manufacturing.
Founded
2006
Focus
Small Molecules
About
Cosmo empowers people to live and work with confidence by innovating at the intersection of science and technology, in the spaces of MedTech AI, dermatology, gastroenterology, and contract manufacturing.
Pipeline Snapshot
55 drugs in pipeline, 1 in Phase 3
| Drug | Indication | Stage |
|---|---|---|
| Methylene Blue MMX® + Placebo | Colorectal Cancer | Phase 3 |
| Methylene Blue MMX tablets | Colorectal Cancer | Phase 2 |
| CB-10-01 (Transgenic Lymphocyte Immunization) | Stage IIIB Skin Melanoma | Phase 2 |
| Transgenic Lymphocyte Immunization Vaccine (TLI) | Prostatic Neoplasms | Phase 1 |
| Rifamycin SV-MMX® 600 | Healthy | Phase 1 |
Company Info
TypePrivate
Founded2006
LocationDublin, Ireland
StagePhase 3
Contact
SIMILAR COMPANIES
Remedy Biologics
Pre-clinical · Dublin
Aerogen
Pre-clinical · Galway
Bio Pharma Technical Consulting
Pre-clinical · Dublin
Astoriom
Pre-clinical · Dublin
Atlantia Clinical Trials
Pre-clinical · Cork
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile